Journal article
Vernakalant versus procainamide for rapid cardioversion of patients with acute atrial fibrillation (RAFF4): randomised clinical trial
Abstract
OBJECTIVE: To conduct a randomised, open label comparison of the effectiveness and safety of intravenous vernakalant and intravenous procainamide for the management of acute atrial fibrillation in the emergency department.
DESIGN: Randomised clinical trial (RAFF4 trial).
Authors
Stiell IG; Taljaard M; Eagles D; Yadav K; Vadeboncoeur A; Hohl CM; Archambault PM; Birnie D; Brown E; Campbell SG
Journal
The BMJ, Vol. 391, ,
Publisher
BMJ
DOI
10.1136/bmj-2025-085632
ISSN
0959-8138